Myeloperoxidase-dependent LDL modifications in bloodstream are mainly predicted by angiotensin II, adiponectin, and myeloperoxidase activity: a cross-sectional study in men

Mediators of Inflammation
Karim Zouaoui BoudjeltiaThierry Roumeguère

Abstract

The present paradigm of atherogenesis proposes that low density lipoproteins (LDLs) are trapped in subendothelial space of the vascular wall where they are oxidized. Previously, we showed that oxidation is not restricted to the subendothelial location. Myeloperoxidase (MPO), an enzyme secreted by neutrophils and macrophages, can modify LDL (Mox-LDL) at the surface of endothelial cells. In addition we observed that the activation of the endothelial cells by angiotensin II amplifies this process. We suggested that induction of the NADPH oxidase complex was a major step in the oxidative process. Based on these data, we asked whether there was an independent association, in 121 patients, between NADPH oxidase modulators, such as angiotensin II, adiponectin, and levels of circulating Mox-LDL. Our observations suggest that the combination of blood angiotensin II, MPO activity, and adiponectin explains, at least partially, serum Mox-LDL levels.

References

Jul 1, 1994·The Journal of Clinical Investigation·A DaughertyJ W Heinecke
Aug 19, 2003·Atherosclerosis·Lars Lind
Feb 4, 2005·Journal of Leukocyte Biology·Seymour J Klebanoff
May 16, 2006·Biochimica Et Biophysica Acta·Ernst MalleMichael J Davies
Mar 12, 2008·Antioxidants & Redox Signaling·Michael J DaviesMartin D Rees
Mar 15, 2011·Wilderness & Environmental Medicine·Scott E McIntoshTod Schimelpfenig
Mar 19, 2011·Current Opinion in Lipidology·Heidi Noels, Christian Weber
Nov 9, 2011·Nature Medicine·Christian Weber, Heidi Noels
Aug 29, 2013·Mediators of Inflammation·Cédric DelporteKarim Zouaoui Boudjeltia

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA

Software Mentioned

SigmaPlot

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.